Test to detect HPV linked to cervical cancers up for FDA approval
from Cervical Cancer News
Becton, Dickinson and Company has submitted a pre-market approval application to the U.S. Food and Drug Administration for its Onclarity HPV Assay, a test for human papillomavirus. There are more than 100 types of HPV, of which at least 13 are known to cause cancer. Two HPV types in particular, 16 and 18, cause 70 percent of cervical cancers and precancerous cervical lesions.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063